Evidence map›Paper›PMID 33231557›Full record

ArticleJMIR cardio2020

Interdisciplinary Mobile Health Model to Improve Clinical Care After Heart Transplantation: Implementation Strategy Study.

Mar Gomis-Pastor, Sonia Mirabet, Eulalia Roig, Laura Lopez, Vicens Brossa, Elisabeth Galvez-Tugas, Esther Rodriguez-Murphy, Anna Feliu, Gerardo Ontiveros, Francesc Garcia-Cuyàs and 2 more

Open access · goldAbstract read
In one paragraph

Article in JMIR cardio, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Mar Gomis-PastorPharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4097-9316
Sonia MirabetHeart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5955-2748
Eulalia RoigHeart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0002-3421-4985
Laura LopezHeart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0002-8653-6206
Vicens BrossaHeart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0003-0403-6425
Elisabeth Galvez-TugasHeart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0003-3373-9269
Esther Rodriguez-MurphyPharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0001-9262-183X
Anna FeliuPharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0003-2074-2231
Gerardo OntiverosInformation System Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0002-0688-8886
Francesc Garcia-CuyàsDeputy Medical Director, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0002-2448-5466
Albert SalazarDirector Manager, Hospital Universitari Vall Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0003-2385-0561
M Antonia ManguesPharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.ORCID https://orcid.org/0000-0002-1438-8515
Hospital de Sant Pau · ESHospital Sant Joan de Déu Barcelona · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSolid organ transplantation could be the only life-saving treatment for end-stage heart failure. Nevertheless, multimorbidity and polypharmacy remain major problems after heart transplant. A technology-based behavioral intervention model was established to improve clinical practice in a heart transplant outpatient setting. To support the new strategy, the mHeart app, a mobile health (mHealth) tool, was developed for use by patients and providers.

objectiveThe primary objective of this study was to describe the implementation of the mHeart model and to outline the main facilitators identified when conceiving an mHealth approach. The secondary objectives were to evaluate the barriers, benefits, and willingness to use mHealth services reported by heart transplant recipients and cardiology providers.

methodsThis was an implementation strategy study directed by a multidisciplinary cardiology team conducted in four stages: design of the model and the software, development of the mHeart tool, interoperability among systems, and quality and security requirements. A mixed methods study design was applied combining a literature review, several surveys, interviews, and focus groups. The approach involved merging engineering and behavioral theory science. Participants were chronic-stage heart transplant recipients, patient associations, health providers, stakeholders, and diverse experts from the legal, data protection, and interoperability fields.

resultsAn interdisciplinary and patient-centered process was applied to obtain a comprehensive care model. The heart transplant recipients (N=135) included in the study confirmed they had access to smartphones (132/135, 97.7%) and were willing to use the mHeart system (132/135, 97.7%). Based on stakeholder agreement (>75%, N=26), the major priorities identified of the mHealth approach were to improve therapy management, patient empowerment, and patient-provider interactions. Stakeholder agreement on the barriers to implementing the system was weak (<75%). Establishing the new model posed several challenges to the multidisciplinary team in charge. The main factors that needed to be overcome were ensuring data confidentiality, reducing workload, minimizing the digital divide, and increasing interoperability. Experts from various fields, scientific societies, and patient associations were essential to meet the quality requirements and the model scalability.

conclusionsThe mHeart model will be applicable in distinct clinical and research contexts, and may inspire other cardiology health providers to create innovative ways to deal with therapeutic complexity and multimorbidity through health care systems. Professionals and patients are willing to use such innovative mHealth programs. The facilitators and key strategies described were needed for success in the implementation of the new holistic theory-based mHealth strategy.

Indexed as

cardiologyeHealthhealth care modelhealth care technologyheart transplantationimplementation strategyintegrated health care systemsinterdisciplinary health teammedication therapy managementmHealth

Identifiers

PMID33231557
PMCPMC7723747
OpenAlexW3109162145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.